Maximum Strength Acid Reducer — Class II drug recall D-1026-2020
Terminated recall by Perrigo Company PLC, reported 2020-03-25, distributed nationwide. CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
| Recall number | D-1026-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Perrigo Company PLC, Allegan, MI, United States |
| Recall initiated | 2019-10-23 |
| Classified | 2020-03-13 |
| Reported by FDA | 2020-03-25 |
| Terminated | 2020-11-06 |
| Distributed | Nationwide (US) |
| Reason classes | cgmp, specification failure |
| NDC | 00113-7852-01, 00363-0852-01, 11822-0852-04, 30142-0600-56, 41250-0852-01, 55910-0011-01, 59779-0540-01, 63981-0852-56, 68391-0852-56 |
| Lot numbers | 8AE1779, 8AV1095, 8AV1150, 8AV1235, 8AV1236, 8AV1237, 8BE1414, 8BV0896, 8BV0897, 8BV0910, 8BV1737, 8BV1757, 8BV1758, 8CE1446, 8CV0930, 8CV1316, 8CV1317, 8CV1319, 8CV1324, 8CV1633, 8DE1199, 8DE1200, 8DE1532, 8DE1740, 8DV1128, 8DV1129, 8DV1134, 8EE1321, 8EV0993, 8EV0994, 8EV0995, 8EV1240, 8FE1238, 8FE1239, 8FE1346, 8FE1793, 8FE1794, 8FV0712, 8FV0912, 8FV0913 and 69 more |
Product
Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 95 tablets per bottle. [Brand, NDC] NDC Basic Care: 0113-7852-01; NDC Berkley Jensen: 68391-852-56; NDC: CVS Health: 59779-540-01; NDC DG Health: 55910-011-01; NDC Kirkland: 63981-852-56; NDC Kroger: 30142-600-56; NDC Meijer: 41250-852-01; NDC Rite Aid: 11822-0852-4; NDC Walgreens: 0363-0852-01
Reason for recall
CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1026-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.